News
XenoTech Provides Pooled Human Liver Homogenate for Evaluation of Drug Metabolizing Enzymes and Proteins
XenoTech now offers pooled human liver homogenate as part of its extensive catalog of cell and tissue-based products. This test system is ideal...
XenoTech Plans Expansion to New Global Headquarters after Impressive Revenue Growth in 2014
Lenexa, KS (April 21, 2015) – Contract Research Organization XenoTech, LLC has announced plans to relocate into a new 41,500 ft2 facility....
Case Study: XenoTech Ensures Quality
XenoTech: Achieving Reliable, Trustworthy Data for the Drug Discovery and Development Industry – A case study from Artel A drying pipeline. Exorbitant...
XenoTech Scientists Solve Long-Standing Mystery in Drug Metabolism
XenoTech Scientists Solve Long-Standing Mystery in Drug Metabolism A long-standing mystery solved: The formation of 3-hydroxydesloratadine is catalyzed by CYP2C8...
XenoTech Teams Up with JCRB to Provide Access to Over 1,100 Cell Lines in North America
XenoTech Teams Up with JCRB to Provide Access to Over 1,100 Cell Lines in North America XenoTech and the Japanese...
XenoTech Receives US Patent for Its Novel Approach to Evaluate Therapeutic Proteins as Immune Modulators of Drug Metabolism
Lenexa, KS- XenoTech has been awarded US patent # 8,846,576 “In Vitro Test System to Evaluate Xenobiotics as Immune-Modulators of Drug Transport...
Joint XenoTech / Provectus Article Published by Xenobiotica
Provectus Announces PV-10’s Assessment For Drug-Drug Interaction Potential Is Subject Of Article Published By Xenobiotica Knoxville, TN, January 29th, 2014...